Net Cash Provided by (Used in) Financing Activities of REGENEREX PHARMA, INC. from 30 Nov 2010 to 30 Jun 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
REGENEREX PHARMA, INC. quarterly and annual Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 30 Nov 2010 to 30 Jun 2025.
  • REGENEREX PHARMA, INC. Net Cash Provided by (Used in) Financing Activities for the quarter ending 30 Jun 2025 was $2,652, a 105% decline year-over-year.
  • REGENEREX PHARMA, INC. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $2,279,232, a 392% increase from 2023.
  • REGENEREX PHARMA, INC. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $463,084, a 509% increase from 2022.
  • REGENEREX PHARMA, INC. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $76,057, a 2.4% increase from 2021.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Trailing 12 Months (USD)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)

REGENEREX PHARMA, INC. Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q2 2025 $2,652 -$57,612 -105% 01 Apr 2025 30 Jun 2025 10-Q 14 Aug 2025 2024 Q1
Q2 2024 $54,960 -$136,525 -71% 01 Apr 2024 30 Jun 2024 10-Q 14 Aug 2025 2024 Q1
Q2 2023 $191,485 +$157,385 +462% 01 Apr 2023 30 Jun 2023 10-Q 07 Aug 2024 2024 Q1
Q2 2022 $34,100 +$12,555 +58% 01 Apr 2022 30 Jun 2022 10-Q 14 Aug 2023 2023 Q1
Q2 2021 $21,545 +$14,564 +209% 01 Apr 2021 30 Jun 2021 10-Q 09 Aug 2022 2022 Q1
Q2 2020 $6,981 -$60,277 -90% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021 2021 Q1
Q2 2019 $67,258 +$66,946 +21457% 01 Apr 2019 30 Jun 2019 10-Q 12 Aug 2020 2020 Q1
Q2 2018 $312 -$32,791 -99% 01 Apr 2018 30 Jun 2018 10-Q/A 29 Jul 2019 2019 Q1
Q2 2017 $33,103 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018 2018 Q1
Q4 2014 $72,803 $15,796 +$12,960 +457% 01 Sep 2014 30 Nov 2014 10-K 03 Mar 2015 2014 FY
Q3 2014 $59,843 $14,007 -$10,993 -44% 01 Jun 2014 31 Aug 2014 10-Q 20 Oct 2014 2014 Q3
Q2 2014 $70,836 $33,000 +$13,000 +65% 01 Mar 2014 31 May 2014 10-Q 23 Jul 2014 2014 Q2
Q1 2014 $57,836 $10,000 +$11,136 01 Dec 2013 28 Feb 2014 10-Q 11 Apr 2014 2014 Q1
Q4 2013 $46,700 $2,836 -$16,358 -85% 01 Sep 2013 30 Nov 2013 10-K 03 Mar 2015 2014 FY
Q3 2013 $63,058 $25,000 -$5,336 -18% 01 Jun 2013 31 Aug 2013 10-Q 20 Oct 2014 2014 Q3
Q2 2013 $68,394 $20,000 +$15,000 +300% 01 Mar 2013 31 May 2013 10-Q 23 Jul 2014 2014 Q2
Q1 2013 $53,394 $1,136 -$21,136 -106% 01 Dec 2012 28 Feb 2013 10-Q 12 Apr 2013 2013 Q1
Q4 2012 $74,530 $19,194 01 Sep 2012 30 Nov 2012 10-K 28 Feb 2014 2013 FY
Q3 2012 $30,336 01 Jun 2012 31 Aug 2012 10-Q 02 Oct 2013 2013 Q3
Q2 2012 $5,000 -$7,000 -58% 01 Mar 2012 31 May 2012 10-Q 15 Jul 2013 2013 Q2
Q1 2012 $20,000 01 Dec 2011 29 Feb 2012 10-Q 12 Apr 2013 2013 Q1
Q2 2011 $12,000 01 Mar 2011 31 May 2011 10-Q 16 Jul 2012 2012 Q2

REGENEREX PHARMA, INC. Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $2,279,232 +$1,816,148 +392% 01 Apr 2024 31 Mar 2025 10-K 30 Jun 2025 2024 FY
2023 $463,084 +$387,027 +509% 01 Apr 2023 31 Mar 2024 10-K 30 Jun 2025 2024 FY
2022 $76,057 +$1,797 +2.4% 01 Apr 2022 31 Mar 2023 10-K 24 Jun 2024 2023 FY
2021 $74,260 +$10,166 +16% 01 Apr 2021 31 Mar 2022 10-K 09 Jun 2023 2023 FY
2020 $64,094 -$149,999 -70% 01 Apr 2020 31 Mar 2021 10-K 28 Jun 2022 2022 FY
2019 $214,093 +$80,216 +60% 01 Apr 2019 31 Mar 2020 10-K 23 Jun 2021 2020 FY
2018 $133,877 +$80,027 +149% 01 Apr 2018 31 Mar 2019 10-K/A 11 Aug 2020 2019 FY
2017 $53,850 +$51,277 +1993% 01 Apr 2017 31 Mar 2018 10-K 24 Jun 2019 2018 FY
2016 $2,573 01 Apr 2016 31 Mar 2017 10-K 21 Jun 2018 2017 FY
2014 $72,803 +$26,103 +56% 01 Dec 2013 30 Nov 2014 10-K 03 Mar 2015 2014 FY
2013 $46,700 -$27,830 -37% 01 Dec 2012 30 Nov 2013 10-K 03 Mar 2015 2014 FY
2012 $74,530 -$6,854 -8.4% 01 Dec 2011 30 Nov 2012 10-K 28 Feb 2014 2013 FY
2011 $81,384 +$52,384 +181% 01 Dec 2010 30 Nov 2011 10-K/A 28 Feb 2013 2012 FY
2010 $29,000 01 Dec 2009 30 Nov 2010 10-K 28 Feb 2012 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.